GI Clin Med liver Flashcards
Hepatitis
Inflammation of the liver
What can cause hepatitis
Hep A, B, C, D, E
Drugs and toxic agents
*clinical manifestations may be similar regardless of cause
True liver function tests
PT/INR
Albumin
Cholesterol
*alt/ast and alp and bilirubin ldh and get can come from other places “liver tests”
What causes mile elevations in ALT
Chronic hep b, c, d
Acute viral hep (A-E, EBV, CMV)
Steatosis/steatohepatitis
Hemochromatosis
Medications/toxins
Autoimmune hepatitis
Alpha-1 antitrypsin defiency
Wilson disease
Celiac disease
Glycogenic hepatopathy
Mild elevations AST
Alcohol related liver injury
Nonhepattic mild elevations
Strenuous exercise
Hemolysis
Myopathy
Thyroid disease
Macro-ast
Severe elevations ast/alt
Acute viral hepatitis a-e Medications/toxins Ischemic hepatitis Wilson Acute bile duct obstruction Acute budd chairi syndrome Hepatic artery ligation
Non hepatic sources bilirubin
Rbc
Non hepatic sources ast
Skeletal msucles, cardiac muscle, rbc
Non hepatic sources alt
Skeletal muscle, cardiac muscle, kidney
Nonhepatic source led
Heart, rbc,
Non hepatic source alkaline phosphatase
Bone, first trimester placenta, intestines
Hepatocellular disease-primary injury to hepatocytes
Ast, alt higher than alkaline phosphatase
Elevated direct bilirubin
Elevated or normal indirect bilirubin
Associated liver enzymes often elevated
Cholestatic liver disease-injury to bile ducts
Alkaline phosphatase higher than AsT, ALT
Elevation of alkaline phosphatase with near normal ast, alt levels
Normal direct bilirubin
Elevated indirect
No abnormal liver tests; no anemia, onset in late adolescence, fasting makes bilirubin rise
Hemolysis
Normal direct bilirubin
Elevation represents more than 90% of total bilirubin
Anemia usual; increased reticulocyte count, normal liver enzyme levels (LDH may be up)
Overall hepatocellular
ALT >AST
Both up
Cholestasis
ALP up(if isolated consider bone involvement) Check get
Elevated alp Failure of bile to reach duodenum Jaundice and pruritus Pure cholstatsis Oral contraceptives, anabolic steroids sex hormones
Non inflammatory drug induced cholestasis
Anabolic steroids, azathripine, cyclosporine, estrogens
Inflammatory drug induced cholestasis
Amoxicillin
Clinical presntation viral hepatitis
Malaise, nausea, vomiting, diarrhea, low grade fever followers by dark urging, jaundice and tender hepatomegaly; may be subclinical and detected on basis of elevated aspartate and alanine levels
Hep a
Ss RNA hepatovirus (picornavirus family0
Prodrome hep a
Anorexia, nausea, vomiting, malaise, aversion to smoking
Duration hep a
2-3 weeks
Complete clinical 9 weeks recovery 6-12 months no clinical sequelae
Risk factor hep a
1 international travel contaminated water or food, including inadequately cooked shellfish
Symptoms hep a
Fever, malaise, myalgia, arthralgias, easy fatigability, upper respiratoy symptoms, anorexia, enlarged and tender liver, jaundice , nausea, vomiting, diarrhea or constipation
More severe in adults
Ab pain RUQ or epigastric
Alcoholic stools
Transmission hep a
Fecal oral
Poor sanitation crowding
Excreted in feces for up to 2 weeks before clinical illness but rarely after the first week of illness
Labs hep a
Markedly elevated AST ALT
Elevated bilirubin and ALP-cholestasis
Anti hAC IgM early later IgG
Acute hep-IgM diagnose igG-protective and previous exposure
Vaccine HAV
Yup
Hep with fulminant
ABD
Hep B
Hepadna virus partially dsDNA inner core and outer surface coat
Prodrome hep b
Anorexia, nausea, vomiting, malaise, aversion to smoking
Duration hep B
Acute illness usually subsides over 2-3 weeks->complete clinical laboratory recovery 16 weeks
Risk factors hep b
MSM Inject drugs HIV Hemodialysis Physicians, dentists, nurses, personnel working in clinical and pathology laboratories and blood bands Incarcerated STD Blood transfusion
Symptoms hep b
Fever low grade, enlarged and tender liver, jaundice
Asymptomatic w/o jaundice->a fulminating disease and death
Glomerulonephritis, serum sickness, and polyarthritis nodosa
Transmission hep b
Blood or blood products
Sex
Perinatal Asia africa
HBsAg positive mothers 90% transmit to baby
Labs hep b
Markedly elevated ALT AST easily higher than HAV
No cholestasis so ALP and bilirubin normal
Vaccine HBV
Ok
What percent of hep b is acute vs chronic
90% acute
10% chronic
Mortality hep b
Fulminant hepatitis less than 1% with mortality 60%
Prevent hep b
Vaccine
HBIG if exposure in unvaccinated
HBc-AB IgG
Prior infx
Chronic infx
HBsAg
Surface antigen, first evidence, positive during acute and carrier (chronic)
Before biochemical evidence of liver disease and persisting throughout the clinical illness
Persistence of HBsAg more than 6 months after the acute illness
HBsAb
Surface antibody, immunity
Appears after clearance of HBsAg and after successfulvaccination
HBcAg
Core antigen
HBcAb IgM
Appears shortly after HBsAg is detected, ONLY THING DETECTABLE DURING GAP WINDOW PERIOF->CONSIDERED ACUTE HBV
Diagnose acute
Reappear during flares of previously inactive chronic hep b
IgG also persists but persists indefinitely
HBcAb IgG
Appears during late in acute phase and persists indefinitely, whether goes on to chronic infection or immunity (prior infx)
HBeAg
Viral proliferation and infect iv its
+ acute and active chronic
Negative inactive chronic
Secretory form of HBcAg ->viral rep and infectivity
If persist beyond three months->chronic
HBV DNA
Detectable during current infection, typically parallels the presence of HBeAg, more sensitive and precise marker of viral replication
More sensitive precise marker of viral replication
Hep D
Defective RNA virus needs HBV
Risk factor Hep D
HBV endemic Mediterranean basin ; spread predominantly by non percutaneous means
Nonendemic areas-spread percutaneous lh in HBsAg IV drug users or hemophiliac transfusion
Labs HDV
Ani HDV
Vaccine hepD
Vaccinate against hep b
Mortality hep d
Enhances severity of HBV infection
Hep E
RNA hepevirus hepevirdae
Risk factors hep e
Epidemic form in Asia, the Middle East, and North Africa, Central America , India
Pet
Tramsioson hep e
Enteric, cooked organ meat, spread by swine
Labs hep e
IgM anti HEV
Vaccine HEV
Approved in china
Acute HEV chronic
Acute
But in transplant patients treated with tacrolimus instances of chronic with progression to cirrhosis have been reported
Mortality hep e
Pregnant
Hep c
Flavivirus ss RNA Chronic
Risk factors hep c
HIV
Transfusion
Body piercing and tattooed, hemodialysis
Hospital and outpatient facility acquired transmission-re use syringes in caths
Unsafe medical practices
Bloody fisticuffs
Symptoms hep c
Mild and asymptomatic fluctuating elevations of serum ALT AST
Labs hep c
HCV RNA
Enzyme immunoassay that detects antibodies to HCV
What is someone has HCV ins drum, without HCV RNA in serum
Recovery from prior HCV infection
Vaccine hep c
No but chronic carriers should be vaccinated against HAV HBV
Complications HCV
Cirrhosis, hepatocellular carcinoma, HIV coinfection, cryoglobulinemia and membranoproliferative glomerulonephritis, lichen Plano’s, autoimmune thyroiditis, lymphocytes sialadentis, idiopathic pulmonary fibrosis, sporadic porphyria cutaneous tarda, monoclonal gammatopathies
Prevent HCV
Test donated blood
Screen baby boomers
Safe sex
Don’t share razors of tooth brush
Treat hep c
Curable with proper treatment
Chronic hepatitis
At least 6 months
Etiology chronic hepatitis
Hepatitis B virus, hep C, hep D, drugs (methyldopanitrofurantoin, isoniazid, dantrolene), autoimmune hepatitis, Wilson’s, hemochromatosis, a1-antitrypsin defiency)
Chronic hepatitis grade
Histologic assessment of necrosis and inflammatory activity based on exam of liver
State chronic hepatitis
Reflects the level of disease progression and is based not he degree of fibrosis
Presentation chronic hepatitis
Asymptomatic ALT AST Elevations
Acute fulminant
Fatigue, malaise, anorexia, low grade fever, jaundice , ascites, varices bleeping, encephalopathy, coagulopathy, hypersplenium
When do people with chronic hepatitis get extrahepatic manifestations
HBV-urticaria, arthritis, polyarthritis nodosa, vasculitis, polyneuropathy, glomerulonephritis
HCV-mixed cryoglobulinemia
How ID presence or absence of fibrosis in chronic hep
Serum fibrosure and/or US elastography
Toxic and drug induced hepatitis dose dependent
Onset in 48 hours, predictable , necrosis around terminal hepatic venue
Mushroom poisoning, acetaminophen
Toxic and drug induced hepatitis idiosyncratic
Variable dose and time of onset
Small number of exposed persons affected
May be associated with fever, rash, arthralgias, eosinophilia
Ioniazid
Treat toxic and drug induced hepatitis
Supportive -withdraw agent, gastric lovage and oral administration of charcoal
Liver transplant
Acetaminophen overdose, sulfhydryl compounds, use remark Matthew nomogram
-start therapy in 8 hours if ingestion
Fulminant hepatitis
Massive hepatic necrosis with impaired consciousness occurring within 8 weeks of the onset of illness
Causes of fulminant hepatitis
ABCDE Drugs Ischemia Budd chiari syndrome Idiopathic chronic active hep Acute Wilson’s disease Reye’s syndrome acute fatty liver of pregnancy
Clinical fulminant hepatitis
Encephalopathy
Rapidly shrinking liver side, raising bilirubin, prolongation PT, clinical signs of confusion, disorientation, somnolence, ascites and edema-hepatic failure with encephalopathy, ALT AST fall
Cerebral edema,
Mortality fulminant hepatitis
Common
Treat fulminant hepatitis
Maintain fluid balance, support of circulation and respiration, control bleeding, correction of hypoglycemia, and tratment of other complications of the comatose state in anticipation of liver regeneration and repair
Restrict protein intake
Oral lactulose or neomycin
Prophylactic antibiotics -improves survival
Liver transplant
Alcoholic liver disease
80 mg a day men 30-40 mg a day women
Often denied in exam
Men or women more susceptible to get advanced liver disease with less alcohol intake
Women
Cofactors in alcoholic liver disease
Hep B and B malnutrition
Fatty liver alcohol
Asymptomatic and goes away with stopping alcohol
Alcoholic hepatitis
Asymptomatic->severe liver failure with jaundice, ascites, GI bleeding and encephalopathy
Anorexia, nausea, vomiting, fever, jaundice, tender hepatomegaly, RUQ pain
Alcoholic hepatitis AST ALT
AST ALT 2:1
Diagnosis alcoholic hepatitis
Biopsy hepatocyte swelling, mallory denk
Adverse prognosis alcoholic hepatitis
Critically ill
A maddreys discriminates function (PT and serum bilirubin involved)-over 32 associated with poor prognosis
MELD score of end stage liver disease->21 is also significant mortality
Glasgow alcoholic hepatitis scare-predicts mortliaity based on age, serum bilirubin, BUN, prothrombin time, and WBC
Over 9 who receive glucocorticoids had higher survival rates compared to those that didn’t
Ascites, varices hemorrhage, encephalopathy, hepatorenal syndrome poor
Lab of alcoholic hepatitis
Mild liver enzymes Anemia Leukocytosis Leukopenia Thrombocytopenia ALP GGT up PT up Depressed albumin and gamma globulin up Increased transferrin saturation, hepatic iron stores, and sideroblastic anemia Folic acid defiency by
Imaging hepatic alcoholic
UD exclude biliary obstruction and identifies subclinical ascites
CT IV MRI
Serum fibrosure and or US elastography can identify presence or absence of fibrosis
Liver biopsy of alcoholic hepatitis is identical to what
Non alcoholic steatohepatitis
Treat alcoholic hepatitis
Abstinence is essential
Multivitamin
G;ucose administation increases thiamine requirement and can precipitate wernicke korsakoff syndrome if thiamine is not co administered
Wernicke encephalopathy
Confusion, ataxia, involuntary abnormal eye movements
Korsakoff syndrome
Severe memory issues
Confabulation/make up stories to fill in the gaps
Treat korsakoff
Correct K Mg and phosphate deficiencies
Transfusions of packed rbc, plasma as necessary
Monitor glucose
Severe alcholic hepatitis(discrimination function>32 MELD >20) steroids
Pentoxifylline increase survival
Liver transplantation-but must obstinate from alcohol for 6 months to be considered
Non alcoholic fatty liver disease
Asymptomatic elevated ALT AST hepatomegaly
Steatosis without fibrosis
Common 20-45% of Americans
Causes oris factors non alcoholic fatty liver disease
Obesity, DM, hyper TG, insulin resistance
Hispanic
Vinyl chloride
Histology non alcoholic fatty liver
Focal infiltration by polymorphonuclear neutrophils and mallory hyaline similar to non alcoholic steatohepatitis
Symptoms NAFLD
Asymptomatic mild URQ discomfort
Hepatomegaly
Lab NALFLD
Milf elevation ALT AST
Maybe normal though
Imaging NAFLD
CT< US< MRU see macrovascular steatosis
MRU-quantify fat content
US elastography-assess liver stiffness can be used to estimate hepatic fibrosis
Primary biliary cirrhosis
Progressive non supportive destructive intrahepatic cholangitis
Chronic
Autoimmune destruction
FEMALE over 50
Symptoms primary biliary cirrhosis
Asymptomatic isolated elevation in ALP or impaired bile excretion->liver failure and cirrhosis
Risk of primary biliary cirrhosis
UTI
Smoking
Hormone replacement therapy
Hair dye
Clinical manifestations PBC
Pruritus, fatigue, jaundice, xanthelasma, osteoporosis, steatorrhea, skin hyperpig, portal hypertension
Associated disease PBC
Sjirgen autoimmune
Diagnose PBC
AMA 90%
ALP GGT bilirubin, cholesterol IgM
Treat PBC
Ursodeoxycholic
Autoimmune hepatitis 1
More common
Anti smooth msucle antinuclear
Antibodies
Type II autoimmune hepatitis
Women
Antiliver.kidney microsomal antibodies anti LKM
Clinical manifestation autoimmune hepatitis type I
Women
Abrupt onset 1.3 insidious 2/3
Progressive jaundice, anorexia, hepatomegaly, abdominal pain, epistaxis, ever, fatigue
Healthy woman-spider telangiectasia, cutaneous striae, acne, hirstisum, hepatomegaly
Autoimmune hepatitis and cirrhosis
Leads to itwhich causes death if untreated risk of hepatocellular cancer
Extrahepatic manifestations autoimmune hepatitis
Rash, arthralgias, keratoconus TI is sicca, thyroiditis, hemolytic anemia, nephritis, UC
Treat autoimmune hepatitis
Glucocorticoids